XML 22 R11.htm IDEA: XBRL DOCUMENT
v3.20.2

Fair Value of Financial Instruments | 9 Months Ended
--- | ---
Jun. 30, 2020
Fair Value Disclosures [Abstract] |
Fair Value of Financial Instruments | 4. Fair Value of Financial Instruments The Company’s financial instruments generally include cash and cash equivalents, short-term investments, foreign currency forward contracts, trade and other receivables and accounts payable. Due to the short-term maturities of cash and cash equivalents, trade and other receivables and accounts payable, the carrying amounts of these financial instruments are deemed to approximate their fair value on the respective balance sheet dates. The valuation technique used to measure the fair value of the contingent consideration was derived from models utilizing market observable inputs. The Company measures short-term investments and derivatives at fair value on a recurring basis. The following tables present the fair value of the Company’s contingent consideration and foreign currency forward contracts by valuation hierarchy and input (in thousands):
|  | As of June 30, 2020 |
|  | Quoted Prices in Active Markets for Identical Assets (Level 1) |  |  | Significant Other Observable (Level 2) |  |  | Significant Unobservable (Level 3) |  |  | Totals |
Contingent Consideration |  | $ | — |  |  | $ | — |  |  | $ | (11,574 | ) |  | $ | (11,574 | )
Foreign Currency Forward Contract |  |  | — |  |  |  | (13 | ) |  |  | — |  |  |  | (13 | )
Total |  | $ | — |  |  | $ | (13 | ) |  | $ | (11,574 | ) |  | $ | (11,587 | )
|  | As of September 30, 2019 |
|  | Quoted Prices in Active Markets for Identical Assets (Level 1) |  |  | Significant Other Observable (Level 2) |  |  | Significant Unobservable (Level 3) |  |  | Totals |
Contingent Consideration |  | $ | — |  |  | $ | — |  |  | $ | (9,940 | ) |  | $ | (9,940 | )
Foreign Currency Forward Contract |  |  | — |  |  |  | (4 | ) |  |  | — |  |  | $ | (4 | )
Total |  | $ | — |  |  | $ | (4 | ) |  | $ | (9,940 | ) |  | $ | (9,944 | )
Assets and liabilities measured on a nonrecurring basis The measurements utilized to determine the implied fair value of the Company’s contingent consideration as of June 30, 2020 represented significant unobservable inputs (Level 3). The following table summarizes changes in the fair value of the Company’s Level 3 financial instruments for the nine months ended June 30, 2020:
Balance at October 1, 2019 | $ | 9,940 |
Fair value adjustments |  | — |
Balance at December 31, 2019 |  | 9,940 |
Fair value adjustments |  | 972 |
Balance at March 31, 2020 |  | 10,912 |
Fair value adjustments |  | 662 |
Balance at June 30, 2020 | $ | 11,574 |
Adjustments to the fair value of the contingent consideration are based on Monte Carlo simulations utilizing inputs which include market comparable information and management assessments regarding potential future scenarios. The Company believes its estimates and assumptions are reasonable, however, there is significant judgement involved.

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258 + Details
Name: | us-gaap_FairValueDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration